Ledger.Open graph →
SEC Form D · Amendment · filed January 26, 2024

Inflammasome Therapeutics, Inc

Offering
$3.8M
Sold
$3.8M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
NEWTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

James Shephard · EUGENE, ORDirectorStephen Zimba · EUGENE, ORDirectorJayakrishna Ambati · Newton, MADirectorAustin Morris · Marquette, MIExec · DirectorPaul Ashton · Newton, MAExec · DirectorJoon Lee · Newton, MADirectorMary Weber · Newton, MADirectorKenneth Epps · EUGENE, ORDirectorNapoleone Ferrara · Newton, MADirectorNapoleone Ferrara · Newton, MADirectorAdam Kall · Marquette, MIDirectorJayakrishna Ambati · Newton, MADirectorBalamurali Ambati · Newton, MADirectorPaul Ashton · Newton, MAExec · DirectorMary Weber · Newton, MADirectorMichele Zimba · EUGENE, ORDirectorBalamurali Ambati · Newton, MADirectorJoon Lee · Newton, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗